Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

National Grid CEO to leave after 10 years

(Sharecast News) - National Grid has announced that chief executive John Pettigrew is to leave the role after nearly a decade as head of the utilities company. The group said the board and Pettigrew both believe it is the "right time to transition leadership" following a comprehensive succession planning process.

Zoë Yujnovich, currently the head of integrated gas and upstream operations at Shell, has been appointed as Pettigrew's replacement.

National Grid said she is "ideally qualified" with a "proven track record", having held a number of senior roles at Rio Tinto as well as a board position at Unilever.

Pettigrew, who first joined National Grid in 1991 before working his way through progressively senior roles to become CEO in 2016, said in a statement: "It has been an immense honour for me to lead the company I joined as a graduate. All that I have achieved has only been possible because of the many talented people I have had the privilege to work with and learn from."

Yujnovich will join the board in September and replace Pettigrew officially in November to ensure a smooth transition and handover of responsibilities.

"We are delighted to have found such a talented and worthy successor in Zoë Yujnovich, someone who is highly regarded in, and has wide experience of, the energy sector," said chair Paula Reynolds.

"An internationalist in outlook, she has a strong sense of purpose and is an inspiring leader. Further, she will arrive with a notable track record of delivering complicated, large scale capital projects in complex political environments."

Shares were down 1% at 1,072p in early deals on Thursday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.